Clinical trial
Regulation of Inflammatory Mediators in Chronic Obstructive Pulmonary Disease
NCT00147095 · Imperial College London, Other · Completed
Key facts
| NCT number | NCT00147095 |
|---|---|
| Title | Regulation of Inflammatory Mediators in Chronic Obstructive Pulmonary Disease |
| Official title | Regulation of Inflammatory Mediators in Chronic Obstructive Pulmonary Disease |
| Lead sponsor | Imperial College London, Other |
| Collaborators | Gene Logic Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | COPD, Emphysema |
| Enrollment | 80 |
| Start date | Feb 1, 2003 |
| Primary completion | Feb 1, 2005 |
| Completion | Feb 1, 2005 |
| First posted | Sep 7, 2005 |
| Last update posted | Nov 14, 2019 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: